- Home
- NLSP vs MGRX Comparison
NLSP vs MGRX Comparison
Compare NLSP & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- MGRX
- Stock Information
- Founded
- NLSP 2015
- MGRX 2021
- Country
- NLSP Switzerland
- MGRX United States
- Employees
- NLSP N/A
- MGRX N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- MGRX Computer Software: Prepackaged Software
- Sector
- NLSP Health Care
- MGRX Technology
- Exchange
- NLSP Nasdaq
- MGRX Nasdaq
- Market Cap
- NLSP 12.4M
- MGRX 8.1M
- IPO Year
- NLSP 2021
- MGRX 2023
- Fundamental
- Price
- NLSP $2.24
- MGRX $1.71
- Analyst Decision
- NLSP
- MGRX
- Analyst Count
- NLSP 0
- MGRX 0
- Target Price
- NLSP N/A
- MGRX N/A
- AVG Volume (30 Days)
- NLSP 308.9K
- MGRX 173.7K
- Earning Date
- NLSP 07-29-2025
- MGRX 08-13-2025
- Dividend Yield
- NLSP N/A
- MGRX N/A
- EPS Growth
- NLSP N/A
- MGRX N/A
- EPS
- NLSP N/A
- MGRX N/A
- Revenue
- NLSP N/A
- MGRX $511,084.00
- Revenue This Year
- NLSP N/A
- MGRX N/A
- Revenue Next Year
- NLSP N/A
- MGRX N/A
- P/E Ratio
- NLSP N/A
- MGRX N/A
- Revenue Growth
- NLSP N/A
- MGRX N/A
- 52 Week Low
- NLSP $1.30
- MGRX $1.32
- 52 Week High
- NLSP $15.59
- MGRX $7.66
- Technical
- Relative Strength Index (RSI)
- NLSP 46.57
- MGRX 48.03
- Support Level
- NLSP $2.06
- MGRX $1.42
- Resistance Level
- NLSP $2.35
- MGRX $1.72
- Average True Range (ATR)
- NLSP 0.22
- MGRX 0.13
- MACD
- NLSP -0.04
- MGRX 0.01
- Stochastic Oscillator
- NLSP 14.33
- MGRX 71.06
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.